(Q77299224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Interactions between implantable cardioverter-defibrillators and class III agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

C Movsowitz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

F E Marchlinski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

41I-48I

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Implantable defibrillation: eight years clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Long-term outcome with the automatic implantable cardioverter-defibrillator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Interactions between drugs and devices: experimental and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effects of optical enantiomers CK-4000(S) and CK-4001(R) on defibrillation and enhancement of shock-induced extension of action potential duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

The effect of newer antiarrhythmic drugs on defibrillation threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Isoproterenol increases defibrillation energy requirements in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

DL and D sotalol decrease defibrillation energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effect of sotalol on ventricular fibrillation and defibrillation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effects of chronic amiodarone therapy on defibrillation threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Amiodarone-induced refractoriness to cardioversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effect of quinidine and bretylium on defibrillation energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Bretylium decreases and verapamil increases defibrillation threshold in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Termination of ventricular tachycardia: role of tachycardia cycle length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Potential Interactions Between Antiarrhythmic Medication And The Automatic Implantable Cardioverter Defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Clinical safety profile of sotalol in the treatment of arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Adverse effects of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Ventricular Pacing Threshold and Time to Capture Postdefibrillation in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Electrocardiographically Documented Unnecessary, Spontaneous Shocks in 241 Patients With Implantable Cardioverter Defibrillators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Underdetection of ventricular tachycardia using a 40 ms stability criterion: effect of antiarrhythmic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900471-8

10.1016/S0002-9149(98)00471-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737653%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference